Twelve subjects with chronic obstructive lung disease and a partially reversible obstruction received increasing single doses of bopindolol (1, 2, 4, and 8 mg), pindolol (7.5, 15, and 30 mg), and atenolol (50 and 100 mg). Resting heart rate and blood pressure were reduced in a dose-dependent fashion. The actions of the drugs on lung function were assessed by whole body plethysmography. Pindolol did not influence mean airway resistance (Raw). Bopindolol (1, 2 and 4 mg) and atenolol (50 mg) exhibited a neutral effect on mean Raw. Atenolol (100 mg) and to a lesser extent bopindolol (8 mg) induced a long-lasting increase in mean Raw.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF01728185DOI Listing

Publication Analysis

Top Keywords

bopindolol pindolol
8
pindolol atenolol
8
chronic obstructive
8
obstructive lung
8
lung disease
8
atenolol 100
8
bopindolol
4
atenolol
4
atenolol patients
4
patients chronic
4

Similar Publications

Time course for blood pressure lowering of beta-blockers with partial agonist activity.

Cochrane Database Syst Rev

September 2020

Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada.

Background: Beta-blockers are commonly used in the treatment of hypertension. We do not know whether the blood pressure (BP) lowering efficacy of beta-blockers varies across the day. This review focuses on the subclass of beta-blockers with partial agonist activity (BBPAA).

View Article and Find Full Text PDF

Two sensitive fluorometric methods were developed for the determination of both bopindolol malonate (BOP) and celiprolol HCl (CLP) based on measuring their native fluorescence in methanol and acetonitrile, respectively. For BOP, the fluorescence was measured at 316 nm after excitation at 278 nm. The proposed method was successfully applied to the assay of commercial tablets as well as content uniformity testing.

View Article and Find Full Text PDF

Role of chemical structure in stereoselective recognition of beta-blockers by cyclodextrins in capillary zone electrophoresis.

J Biochem Biophys Methods

April 2008

University of Medicine and Pharmacy Târgu-Mureş, Institute of Pharmaceutical Chemistry, Str. Gheorghe Marinescu nr. 38, 540139 Târgu-Mureş, Romania.

Most of the beta-blocking drugs for treating diseases of the cardiovascular system are chiral aryloxy-propanolamine derivatives. Tipically, the S(-) enantiomers are more active than the R(+) enantiomers. Only some of them (for example timolol) are used as single enantiomers, the others are employed as racemates.

View Article and Find Full Text PDF

Transdermal delivery of beta-blockers.

Expert Opin Drug Deliv

May 2006

Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi-110062, India.

Beta-adrenoceptor blocking drugs (beta-blockers) are one of the most frequently used class of cardiovascular drugs that are mainly used in conventional dosage forms., which have their own limitations including hepatic first-pass metabolism, high incidence of adverse effects due to variable absorption profiles, higher frequency of administration and poor patient compliance. Essentially, attempts have been made to develop novel drug delivery systems for beta-blockers, including transdermal delivery systems, to circumvent the drawbacks of conventional drug delivery.

View Article and Find Full Text PDF

Studies on chiral resolution of beta-blocker and H1-antihistamine drugs by CZE using human serum transferrin are described. The drugs with different structures passed a pseudostationary protein zone in a coated capillary applying the partial filling method for the chiral separation. In this study we screened 15 compounds; most of them showed longer migration time, indicating an interaction with transferrin.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!